Abstract
Chronic allograft injury remains the leading cause of graft loss despite improvements in immunosuppression, clinical risk stratification, and state-of-the-art antibody testing. Emerging results indicate that T-cell immune monitoring by cytokine enzyme-linked immunosorbent spot, as part of a comprehensive risk assessment platform, has the potential to guide decision making and improve outcomes after transplantation.
Original language | English |
---|---|
Pages (from-to) | 1157-1158 |
Number of pages | 2 |
Journal | Transplantation |
Volume | 88 |
Issue number | 10 |
DOIs | |
State | Published - Nov 2009 |
Keywords
- ELISPOT
- IFN-γ
- Immune monitoring
- T-cells